Recurrent ventilator-associated pneumonia in severe Covid-19 ARDS patients requiring ECMO support.

Elena Collado-LledóQuentin MoyonJuliette ChommelouxMarc Pineton de ChambrunGuillaume HékimianOuriel SauraDavid LévyMatthieu SchmidtAlain CombesCharles-Edouard LuytLucie Le Fevre

Published in: Annals of intensive care (2024)

In patients with severe Covid-19-ARDS requiring ECMO support, VAP recurrence occurs frequently, with Enterobacteriaceae and Pseudomonas aeruginosa as predominant causative microorganisms. An antimicrobial treatment of ≥ 8 days for the treatment of first VAP episode did not reduce the risk of VAP recurrence, as compared to shorter duration.

Keyphrases

acute respiratory distress syndrome
extracorporeal membrane oxygenation
pseudomonas aeruginosa
coronavirus disease
sars cov
end stage renal disease
newly diagnosed
mechanical ventilation
cystic fibrosis
early onset
respiratory failure
multidrug resistant
peritoneal dialysis
free survival